Albert David Share Price

Overview
Recos
News
Analysis
Financials
Forecast
Technicals
Peers
Shareholdings
MF
F&O
Corp Actions
About

Albert David Share Price

834.9010.90 (1.33%)

Live
As On: 04 Mar, 2025, 11:34 AM IST
As On: 04 Mar, 2025, 11:33 AM IST

Sector: Pharmaceuticals
Industry: Pharma - Indian

1D
1W
1M
3M
6M
1Y
5Y

Loading...

Open	826.95
High	842.25
Low	810.10
Prev Close	824.00
Volume	3,763
VWAP(₹)	827.59

Albert David share price insights

New 52 Week Low
Stock touched a new 52 week low today.
Contingent Liabilities Coverage
Company has sufficient cash reserves to pay off its contingent liabilities. (Source: Standalone Financials)
PAT: Slipping to Red
Company has posted a loss of Rs 9.39 cr in Dec 31, 2024 quarter after 3 consecutive quarter of profits. (Source: Standalone Financials)
Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 57.72% as compared to Nifty Smallcap 100 which gave a return of 48.06%. (as of last trading session)
Albert David Share Price Update
Albert David Ltd. share price moved up by 1.33% from its previous close of Rs 824.00. Albert David Ltd. stock last traded price is 834.90
Share Price Value
Today/Current/Last 834.90834.05
Previous Day 824.00824.40

Found Insights useful?

Albert David Share Price Returns

1 Day	1.33%
1 Month	-28.22%
3 Months	-39.26%
1 Year	-34.23%
3 Years	59.8%
5 Years	98.57%

Key Metrics

PE Ratio(x)	11.78
EPS - TTM(₹)	70.86
MCap(₹ Cr.)	476.29
MCap Rank	85
PB Ratio(x)	1.23
Div Yield(%)	1.38
Face Value(₹)	10.00
52W High(₹)	1,753.95
52W Low(₹)	810.10
MCap/Sales	1.69
Beta(1 Month)	0.81
BV/Share(₹)	671.05

Albert David Share Recommendations

Recent Recos

Target₹570
OrganizationIndependent Analyst
BUY

View all Stock Recommendations

Albert David News & Analysis

View all Albert David Share News & Announcements

Albert David Share Analysis

EARNINGS

FUNDAMENTAL

RELATIVE VALUATION

RISK

PRICE MOMENTUM

Unlock Stock Score, Analyst' Ratings & Recommendations

Score on 10-point scale
Ratings by analysts
Stock performance

JOIN ET PRIME

Albert David Financials

	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023
Total Income	74.08	119.07	112.42	99.50	105.16
Total Income Growth (%)	-37.79	5.92	12.98	-5.39	-0.10
Total Expenses	84.11	93.88	90.26	81.32	81.61
Total Expenses Growth (%)	-10.41	4.01	11.00	-0.36	3.74
EBIT	-10.03	25.19	22.16	18.18	23.55
EBIT Growth (%)	-139.82	13.71	21.85	-22.81	-11.46
Profit after Tax (PAT)	-9.39	18.07	18.84	12.91	18.72
PAT Growth (%)	-151.95	-4.10	45.94	-31.01	-7.79
EBIT Margin (%)	-13.54	21.16	19.71	18.27	22.40
Net Profit Margin (%)	-12.67	15.18	16.76	12.98	17.80
Basic EPS (₹)	-16.45	31.67	33.02	22.63	32.80

	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	420.01	356.96	329.35	264.63	327.91
Total Revenue Growth (%)	17.66	8.38	24.46	-19.30	1.31
Total Expenses	322.73	306.23	282.06	237.19	298.95
Total Expenses Growth (%)	5.39	8.57	18.92	-20.66	1.40
Profit after Tax (PAT)	75.42	36.17	35.26	22.14	19.17
PAT Growth (%)	108.49	2.60	59.23	15.52	-28.05
Operating Profit Margin (%)	26.92	14.98	15.25	11.35	9.27
Net Profit Margin (%)	20.80	10.59	11.24	8.94	5.97
Basic EPS (₹)	132.15	63.39	61.78	38.80	33.59

All figures in Rs Cr, unless mentioned otherwise

Insights

PAT: Slipping to Red
Company has posted a loss of Rs 9.39 cr in Dec 31, 2024 quarter after 3 consecutive quarter of profits. (Source: Standalone Financials)
Quarterly Topline Performance
Company witnessed QoQ revenue decline of 37.79%, which is lowest in the last 3 years. (Source: Standalone Financials)

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Assets	497.99	423.39	402.84	341.40	320.22
Total Assets Growth (%)	17.62	5.10	18.00	6.61	8.41
Total Liabilities	115.01	111.82	123.37	97.02	97.42
Total Liabilities Growth (%)	2.85	-9.36	27.16	-0.41	14.69
Total Equity	382.98	311.57	279.47	244.38	222.80
Total Equity Growth (%)	22.92	11.49	14.36	9.69	5.87
Current Ratio (x)	3.75	3.07	2.33	2.77	2.48
Total Debt to Equity (x)	0.01	0.01	0.01	0.00	0.01
Contingent Liabilities	5.27	8.23	2.81	4.07	4.14

All figures in Rs Cr, unless mentioned otherwise

Insights

Contingent Liabilities Coverage
Company has sufficient cash reserves to pay off its contingent liabilities. (Source: Standalone Financials)

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash flow from Operating Activities	45.50	10.52	40.36	36.61	30.09
Net Cash used in Investing Activities	-33.25	-5.00	-39.70	-36.68	-20.00
Net Cash flow from Financing Activities	-8.27	-6.36	-4.88	-1.71	-10.17
Net Cash Flow	3.99	-0.83	-4.13	-1.77	0.00
Closing Cash & Cash Equivalent	5.44	1.45	-1.49	4.64	6.42
Closing Cash & Cash Equivalent Growth (%)	276.29	-197.04	-132.08	-27.65	0.07
Total Debt/ CFO (x)	0.05	0.38	0.09	0.01	0.05

All figures in Rs Cr, unless mentioned otherwise

Insights

Cash from Operations vs PAT
Operating cash flow of Rs 45.5 cr is 0.6 times compared to the reported net profit of Rs 75.42 cr. (Source: Standalone Financials)
Increase in Cash from Investing
Company has used Rs 33.25 cr for investing activities which is an YoY increase of 565.6%. (Source: Standalone Financials)

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Return on Equity (%)	19.69	11.61	12.61	9.06	8.60
Return on Capital Employed (%)	24.46	15.77	16.27	10.77	12.43
Return on Assets (%)	15.14	8.54	8.75	6.48	5.98
Interest Coverage Ratio (x)	325.13	131.04	106.40	55.62	37.37
Asset Turnover Ratio (x)	0.79	0.83	0.84	0.75	100.18
Price to Earnings (x)	8.14	8.08	8.61	9.72	9.59
Price to Book (x)	1.60	0.94	1.09	0.88	0.82
EV/EBITDA (x)	5.60	4.53	5.10	4.96	4.76
EBITDA Margin (%)	28.81	17.49	18.06	14.68	11.66

Insights

ROE Outperforming 5 Year Average
Company delivered ROE of 19.69% in year ending Mar 31, 2024 outperforming its 5 year avg. of 13.06%. (Source: Standalone Financials)

Found Financials useful?

Albert David Technicals

Buy/Sell Signals
No Data Available
Price Analysis
No Data Available
Pivot Levels
R1 - Pivot
-
S1 -
R2 - S2 -
R3 - S3 -
Average True Range
5 Days 14 Days 28 Days
- - -

Albert David Peer Comparison

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Albert David	11.78	1.24	19.69	24.46	15.14	16.47	26.92	20.80	132.15	3.75	0.01	0.05
Kopran Ltd	17.23	1.67	10.37	14.51	6.85	7.19	12.38	8.29	10.57	2.08	0.20	2.29
Medicamen Bio	80.58	3.06	5.28	8.32	3.71	16.79	9.74	5.29	7.50	1.89	0.15	-4.57
Nectar Lifesc	35.33	0.56	0.46	8.65	0.22	3.13	6.25	0.29	0.22	1.50	0.59	2.83
Wanbury Ltd	12.95	20.34	200.26	46.34	16.29	13.43	10.41	9.72	17.10	0.74	3.94	27.64
Add More

Annual Ratios (%)

Choose from Peers

Kilitch Drug
Ind-Swift Labs
Medico Remedies
Zim Laboratories
Venus Remedies

Choose from Stocks

Stock Performance

CHART
TABLE

1D
1W
1M
3M
6M
1Y
5Y

Choose from Peers
Choose from Stocks

Insights

Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 57.72% as compared to Nifty Smallcap 100 which gave a return of 48.06%. (as of last trading session)
Stock Returns vs Nifty Pharma
Stock generated 57.72% return as compared to Nifty Pharma which gave investors 56.71% return over 3 year time period. (as of last trading session)

Albert David Shareholding Pattern

Total Shareholdings
Category No. of Shares Percentage % Change QoQ
Promoters 35,45,958 62.13 % 0.00
Pledge 0 0.00 % 0.00
FII 49,101 0.86 % -0.02
DII 92,650 1.62 % 0.00
MF 800 0.01 % 0.00
Others 20,19,453 35.39 % 0.02
QoQ Change
Category Dec 2024 Sep 2024 Jun 2024 Mar 2024
Promoters 62.13 62.13 62.13 62.13
Pledge 0.00 0.00 0.00 0.00
FII 0.86 0.88 0.80 0.98
DII 1.62 1.62 1.66 1.66
Mutual Funds 0.01 0.01 0.01 0.01
Others 35.39 35.36 35.41 35.23

Mutual Funds Ownership

No Data Available

Albert David Top Searches

Corporate Actions

Recent
Board Meeting
Quarterly Results
Feb 03, 2025
General Meeting
-
Nov 26, 2024
Board Meeting
Quarterly Results
Nov 06, 2024

Announced on	Meeting on
Feb 03, 2025	Feb 12, 2025
Quarterly Results
Nov 06, 2024	Nov 14, 2024
Quarterly Results
Aug 02, 2024	Aug 09, 2024
Quarterly Results
May 06, 2024	May 13, 2024
Audited Results & Final Dividend
Jan 25, 2024	Feb 05, 2024
Quarterly Results

Dividends
Announced on Ex-Date Dividend%
May 13, 2024 Aug 02, 2024 115%
May 19, 2023 Aug 03, 2023 90%
May 11, 2022 Aug 01, 2022 90%
Jun 17, 2021 Sep 06, 2021 60%
Mar 03, 2020 Mar 13, 2020 70%
Bonus
No Data Available
Splits
No Data Available
Rights
Announced on Ex-Date
Mar 12, 1996 Feb 05, 1996
Rights ratio: 2 share for every 3 held at a price of Rs 20.0
Sep 30, 1993 Mar 26, 1993
Rights ratio: 1 share for every 2 held at a price of Rs 20.0

AGM/EGM Meetings

Announced on	Meeting on
Nov 26, 2024	Dec 28, 2024
-
May 13, 2024	Aug 09, 2024
Book closure from Aug 3, 2024 to Aug 9, 2024
Nov 15, 2023	Dec 18, 2023
-
Jul 18, 2023	Aug 10, 2023
A.G.M.
Jul 05, 2022	Aug 09, 2022
Book closure from Aug 3, 2022 to Aug 9, 2022

About Albert David

Albert David Ltd., incorporated in the year 1938, is a Small Cap company (having a market cap of Rs 470.27 Crore) operating in Pharmaceuticals sector.

Albert David Ltd. key Products/Revenue Segments include Pharmaceuticals, Scrap and Export Incentives for the year ending 31-Mar-2024.

For the quarter ended 31-12-2024, the company has reported a Standalone Total Income of Rs 74.08 Crore, down 37.79 % from last quarter Total Income of Rs 119.07 Crore and down 29.56 % from last year same quarter Total Income of Rs 105.16 Crore. Company has reported net profit after tax of Rs -9.39 Crore in latest quarter.

The company’s top management includes Mr.Arun Kumar Kothari, Mr.Umesh Manohar Kunte, Mr.Anand Vardhan Kothari, Mrs.Prabhawati Devi Kothari, Mr.Anurag Singhi, Dr.Monjori Mitra, Mr.Shirish G Belapure, Mr.Shourya Sengupta, Mr.R Bhattacharya. Company has L B Jha & Co. as its auditors. As on 31-12-2024, the company has a total of .57 Crore shares outstanding.

Albert David Share Price Today is Rs. 834.90. On previous day, the Albert David Share Price (NSE) closed at Rs. 851.3, featuring among the most traded securities on the National Stock Exchange.

Shareholdings:
As of 31st Dec, 2024, the promoter held 62.13% of the stake in Albert David shares, out of which 0.0% was pledged. On the same date, foreign institutional investors' (FII) holdings of Albert David stocks was 0.86% as compared to 0.88% in Sep 2024 with decrease of 0.02%. The domestic institutional investors (DII) holdings on 31st Dec, 2024 was 1.62% as compared to 1.62% in Sep 2024 with decrease of 0.0%. Out of the total DII holdings in Albert David shares 0.01% was held by mutual funds. The rest including public held is 35.39%. Albert David stock price is reflected on both the exchanges - BSE and NSE.

Stock Forecast:
After showing 74.08 Cr. of sales and 37.79% of quarterly net loss, there have been multiple ups and downs in the Albert David stock prices in the past few weeks. For example, Albert David stock price on 24th of February 2025 was around Rs. 856.2. Albert David share price now stands at an average of Rs. 834.90. Judging by last week's performance, stock is in down trend.

Albert David has a median target price of Rs. 0.0 in 12 months by 0 analysts. They have provided a high estimate of Rs. 0.0 and low estimate of Rs. 0.0 for Albert David share.

Historical Prices and Performance:
Albert David, incorporated in 1938 is a Small Cap company (with a market cap of Rs. 470.27) operating in Pharmaceuticals sector.
The Return of Equity (ROE) in last five financial years given by Albert David stock was 19.69%, 11.61%, 12.61%, 9.06% and 8.6% respectively.
The Albert David share gave a 3 year return of 59.95% as compared to Nifty 50 which gave a return of 34.07%.
Albert David announced 115.0% final dividend on August 2, 2024.

Key Metrics:
PE Ratio of Albert David is 12.01
Prices/Sales Ratio of Albert David is 1.69
Price/Book Ratio of Albert David is 1.27

Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. For Albert David, major competitors and peers include Kopran Ltd, Medicamen Bio, Nectar Lifesc and Wanbury Ltd. As of Sep 2024, the dividend yield of Albert David stands at 1.35% while Kopran Ltd, Medicamen Bio, Nectar Lifesc and Wanbury Ltd stand at 1.75%, 0.21%, 0.0% and 0.0% respectively. The PE ratio and PB Ratio of the company are among its competitors stand at 12.01 and 1.27 respectively.

Leadership of Albert David :
A J Chattopadhyay is Corporate Head
R Bhattacharya is Chief Financial Officer
C B Thakur is Head - Operations
S Bhattacharya is Head
Arun Kumar Kothari is Executive Chairman
Umesh Manohar Kunte is Managing Director & CEO
Prabhawati Devi Kothari is Non Executive Director
Anand Vardhan Kothari is Non Executive Director
Anurag Singhi is Ind. Non-Executive Director
Shourya Sengupta is Ind. Non-Executive Director
Shirish G Belapure is Ind. Non-Executive Director
Monjori Mitra is Ind. Non-Executive Director

Show More

Industry

Pharma - Indian

Key Indices Listed On

-

Address

D - Block, 3rd Floor,Gillander House,Netaji Subhas Road,Kolkata, West Bengal - 700001

Contact

adidavid@dataone.in

http://www.albertdavidindia.com

Executive Leadership

AK

Arun Kumar Kothari

Executive Chairman

UM

Umesh Manohar Kunte

Managing Director & CEO

AV

Anand Vardhan Kothari

Non Executive Director

PD

Prabhawati Devi Kothari

Non Executive Director

Show More

Auditors

L B Jha & Co.

Basu Chanchani & Deb

FAQs about Albert David share

1. What's Albert David share price today and what are Albert David share returns ?
As of today Albert David share price is up by 1.33% basis the previous closing price of Rs 851.3. Albert David share price is Rs 834.90.
2. What is 52 week high/low of Albert David share price?
In last 52 weeks Albert David share had a high price of Rs 1,753.95 and low price of Rs 810.10
3. How can I quickly analyze Albert David stock?
Albert David share can be quickly analyzed on following metrics:
- Stock's PE is 11.78
- Price to Book Ratio of 1.23
4. What's the market capitalization of Albert David?
Albert David share has a market capitalization of Rs 476.29 Cr. Within Pharmaceuticals sector, it's market cap rank is 85.
5. What is the CAGR of Albert David?
The CAGR of Albert David is 10.01.
6. Who is the Chief Executive Officer of Albert David?
Umesh Manohar Kunte is the Managing Director & CEO of Albert David
7. What is the PE & PB ratio of Albert David?
The PE ratio of Albert David stands at 11.63, while the PB ratio is 1.23.
8. Who's the chairman of Albert David?
Arun Kumar Kothari is the Executive Chairman of Albert David
9. What are the Albert David quarterly results?
On Standalone basis, Albert David reported a total income and loss of Rs 74.08 Cr and Rs -9.39 respectively for quarter ending resultQuarterlyResult.list[0].yearEnding. Total Income and profit for the year ending 2024-03-31 was Rs 420.01 Cr and Rs 75.42 Cr.
10. Is Albert David giving dividend?
Albert David Ltd. announced an equity dividend of 115% on a face value of 10.0 amounting to Rs 11.5 per share on 13 May 2024. The ex dividend date was 02 Aug 2024.
11. Who's the owner of Albert David?
12. Which are the key peers to Albert David?
Within Pharmaceuticals sector Albert David, Medicamen Biotech Ltd., Medico Remedies Ltd., Ind-Swift Laboratories Ltd., Wanbury Ltd., Nectar Lifesciences Ltd., Zim Laboratories Ltd., Kilitch Drugs(I) Ltd., Lyka Labs Ltd., Kopran Ltd. and Venus Remedies Ltd. are usually compared together by investors for analysis.

Top Gainers

As on 11:32 AM | 04 Mar 2025

Jyoti CNC Automation

866.50

95.75 (12.43%)

Vijaya Diagnostic

1,029.20

96.56 (10.36%)

279.60

23.06 (8.99%)

Concord Biotech Ltd.

1,643.70

122.30 (8.04%)

Alok Industries

16.05

1.17 (7.87%)

Top Losers

As on 11:34 AM | 04 Mar 2025

Astral Poly Tech

1,306.20

-42.15 (-3.13%)

Balkrishna Ind.

2,502.00

-80.50 (-3.12%)

7,480.00

-234.81 (-3.05%)

4,692.25

-141.95 (-2.94%)

780.50

-23.61 (-2.94%)

Equity Quick Links

Top Gainers
Top Losers
Stock Recommendations
Stock Screener
Candlestick Screener
Upcoming Dividends
Volume Shockers
Hourly losers
Hourly gainers

Midcap stocks
Smallcap stocks
Largecap stocks
Sensex
Nifty
NSE
BSE
MCX Live

More from Markets

IPO
Stock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list

Trending in Markets

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.